Filed: 5/15/2026ACC: 0001953107-26-000008
π What this filing means
ENAVATE SCIENCES GP, LLC filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $351.51M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$351.51M
Total AUM (reported)
25.08M
Total Shares
Allocation by class
COM$328.00M93.3%
COM NEW$23.51M6.7%
Portfolio Concentration
Top 3$255.00M72.5%
4β10$96.51M27.5%
Top 3 weight
72.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 25.08M
Sole
Full voting authority
25.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
SIONNA THERAPEUTICS INC
SOLEShares2.48M
TypeSH
Market value$99.34M
28.26%
Sole
2.48M
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares3.61M
TypeSH
Market value$79.03M
22.48%
Sole
3.61M
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares3.92M
TypeSH
Market value$76.62M
21.80%
Sole
3.92M
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares7.79M
TypeSH
Market value$41.20M
11.72%
Sole
7.79M
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares2.63M
TypeSH
Market value$23.51M
6.69%
Sole
2.63M
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares2.46M
TypeSH
Market value$22.14M
6.30%
Sole
2.46M
Shared
0.00
None
0.00
CAMP4 THERAPEUTICS CORP
SOLEShares2.19M
TypeSH
Market value$9.66M
2.75%
Sole
2.19M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SIONNA THERAPEUTICS INCSOLE | COM | 2.48M | SH | $99.34M 28.26% | 2.48M | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 3.61M | SH | $79.03M 22.48% | 3.61M | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 3.92M | SH | $76.62M 21.80% | 3.92M | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 7.79M | SH | $41.20M 11.72% | 7.79M | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 2.63M | SH | $23.51M 6.69% | 2.63M | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 2.46M | SH | $22.14M 6.30% | 2.46M | 0.00 | 0.00 |
CAMP4 THERAPEUTICS CORPSOLE | COM | 2.19M | SH | $9.66M 2.75% | 2.19M | 0.00 | 0.00 |